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THE aetiology of anencephaly and/or spina bifida (neural tube defects) is still
obscure. Most investigators are now agreed on a multifactorial causation with an
important genetic factor and a substantial environmental component. The genetic
factor is probably polygenic, but the mechanism by which it acts remains unknown.
Recently, drugs that stimulate ovulation, particularly clomiphene, have been
implicated in the aetiology of neural tube defects (Dyson & Kohler, 1973; Sandler,
1973; Barrett & Hakim, 1973; Field & Kerr, 1974). Although six infants with
anencephaly and/or spina bifida have been born to mothers receiving clomiphene,
it is impossible on present evidence to conclude whether the malformation rate for
neural tube defects is greater than would have been expected. This report describes
four patients on clomiphene who produced a total of five infants each with a neural
tube defect.
CASE REPORTS
Patient 1. This patient was aged 20 years when first seen on November 29, 1971,
because of secondary amenorrhoea. Since her menarche at age 19 years, she had had
only one menstrual period (February, 1971). Clinical examination was normal
except for hirsutes on the thighs and upper arms and poor breast development.
The uterus was small, mobile, and anteverted. Skull X-rays, adrenal steroid ex-
cretion and thyroid function tests were normal.
Treatment by clomiphene, 50 mgms. daily for five days was commenced on
March 27, 1973. A pregnancy test was positive on May 14, 1973. At examination
on May 21, 1973 and on June 8, 1973 the size of the uterus corresponded to six
weeks and eight weeks gestation respectively. From July 1973, the size of the
uterus 'was always in excess of the period of amenorrhoea. On October 12, 1973,
the size of the uterus corresponded to 32 weeks, whereas the interval since ovulation
was 26 weeks. An ultrasonic scan confirmed gross polyhydramnios and the absence
of a fetal skull. A transabdominal amniocentesis was carried out; the amniotic fluid
alpha-fetoprotein level was 43.0 sg/ml. At 26 weeks gestation the mean amniotic
fluid alpha-fetoprotein level is 3.15 Lg/ml; and the 95th percentile 5.82 ,ug/ml
(Nevin, Thompson & Nesbitt, 1974). A straight X-ray confirmed the presence of an
anencephalic fetus. Five days later, following induction, the patient delivered a
stillborn female fetus weighing 1134 g with anencephaly and a meningomyelocele.
Patient 2: This patient, aged 23 years was first seen in February 1972. She had a
normal menarche, aged 11 years, with menstrual periods lasting 21 to 35 days. For
six months after her marriage in April, 1969, she had been taking an oral contra-
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For the next two and a half years, she had been trying unsuccessfully to conceive.
Clinical and pelvic examination was normal. The uterus was anteverted and of
normal size. There was no histoligical evidence of cyclic activity in the endometrium.
Tubal insufflation was normal. In addition, vaginal cytology on five occasions from
September 13, 1972 to October 11, 1972, showed no evidence of oestrogenic fluc-
tuation throughout the cycle or any indication that ovulation had occurred.
The following courses of clomiphene, each lasting five days, were started in
1973:-
March, 23 50 mg daily
May, 9 100 mgdaily
June, 6 200 mg daily
The temperature chart indicated that ovulation had occurred on July 20, 1973, but
a subsequent pregnancy test on August 1, 1973 was negative. She had a normal
menstrual period on October 14, 1973. Further courses of clomiphene, each lasting
five days was given on: -
March, 1974 400 mg daily
April, 1974 400 mgdaily
June, 1974 400 mg daily
She had a normal menstrual period on June 14, 1974. She had had only two and a
half days treatment of the last course of clomiphene. On July 31, 1974, the size of
the uterus corresponded to 6 to 8 weeks gestation. A pregnancy test on August 1,
1974, was positive.
At 24 weeks gestation on December 18, 1974, she was admitted to hospital be-
cause of an intrauterine death. Following syntocinon induction, on December 19,
1974, she was delivered of a macerated male fetus, weighing 590 g with iniencephaly.
Patient 3: This patient who was born May 31, 1951, was married on February 6,
1970. Her first pregnancy on March 26, 1972 was a stillborn anencephalic female.
There had been no history of clomiphene treatment during this pregnancy. In 1972
her second pregnancy ended in a spontaneous abortion at 10 weeks gestation. This
pregnancy was followed by secondary amenorrhoea. The following courses of
clomiphene, each lasting five days were given in 1973:-
March, 1973 50 mgdaily
April, 1973 50 mgdaily
May, 1973 50 mg daily
The temperature chart indicated that ovulation had occurred on May 23, 1973. The
pregnancy progressed normally. On March 14, 1974, she delivered a female with
microcephaly and an encephalocele. The infant died 30 minutes after birth.
Patient 4: This patient, aged 22 years, was first seen in 1968 because of irregular
menses. Her menarche was at the age of 17 years. Examination did not reveal any
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2 inches. Histologically, the endometrium showed only proliferative phase.
She was married in 1970 and two years later was again seen because of irregular
menses. In the last 8 months she had had only two menstrual periods. Skull X-ray,
thyroid function tests and steroid analysis were normal. Clomiphene therapy, 50 mg
daily for five days, was started on July 31, 1972, and this was increased to 100 mg
daily for five days on August 3, 1972. The temperature chart suggested that ovula-
tion had occurred on August 20, 1972. Pregnancy tests on September 11 and 18,
1972, were positive, but two subsequent tests (September 19 and 20) were negative.
She began to stain vaginally on September 16 and, as this failed to subside, a
dilatation and curettage was undertaken on September 22, 1972. Histologically, the
endometrium showed decidual reaction.
A third course of clomiphene, 100 mg daily for 5 days was given on November 7,
1972. No further treatment was given until September, 1973, when she had a fourth
course of clomiphene-100 mg daily for five days. The temperature chart suggested
that ovulation had taken place on October 1, 1973. On November 5, 1973, the
pregnancy test was positive. Spontaneous labour took place on June 23, 1974, and
she delivered a female infant with microcephaly, frontal encephalocele, and a
meningomyelocele. This baby died 3 hours later.
A fifth course of clomiphene-100 mg daily for 5 days was given on May 6,
1975. Slight vaginal bleeding occurred on June 28 and July 4, 1975. On July 11,
1975, the size of the uterus corresponded to 11 weeks gestation. On July 14, 1975,
she had an episode of crampy low back pain, and two days later, fresh vaginal
bleeding. The pregnancy terminated on July 19, 1975 in a spontaneous abortion;
the fetus had anencephaly.
DISCUSSION
The use of ovulation stimulation agents such as clomiphene in the management of
infertility has become widespread. Until recently, the only problems encountered
in the use of clomiphene has been the high incidence of multiple pregnancy, and a
high rate of early abortion (Whitelaw, et al, 1970; Murray, et al, 1971; Hack, et al
1972). Within the past few years, it has been suggested that clomiphene may have a
teratogenic action (Table). In 1973, Dyson and Kohler, described two patients
who produced infants with anencephaly and spina bifida following treatment with
clomiphene. Since this initial report, several similar observations have been reported
(Sandler, 1973; Barrett & Hakim, 1973; Field & Kerr, 1974). To date there have
been six patients on clomiphene who had infants with a neural tube defect (Table).
The present paper describes four women receiving clomiphene who produced five
infants with a neural tube defect; two had anencephaly and/or spina bifida; of the
remaining three cases one had iniencephaly; another microcephaly and an encephal-
ocele, and the fifth microcephaly, frontal encephalocele and meningomyelocoele.
Interestingly, although clomiphene has been used extensively in the United States,
there are no published reports suggesting a casual association of neural tube defects
and clomiphene.
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Neural-tube Defects folldwing Ovulation Stimulation by Clomiphene
Birth
Author Case Previous Obstetric History Sex Weight Description of
(g) Abnormality
Dyson & Kohler
(1973)
1 Primigravida
2 One spontaneous abortion
F 1030 Cervical spina bifida,
anencephaly, kyphoscolosis
of thoracic spine and mild
bilateral hydronephrosis
M NR Anencephaly
M 936 Anencephaly and severe
spina bifida
Barrett & Hakim
(1973)
Field & Kerr
(1974)
Present Authors
(1975)
I Four previous pregnancies;
first a female anencephalic
infant; and the other 3
normal female infants
1 One normal male while on
clomiphene therapy
2 Primigravida
I Primigravida
2
3
Primigravida
Two pregnancies; first a
stillborn anencephalic
infant; and the other a
spontaneous abortion
4 One spontaneous abortion
while on clomiphene
M
M
NR Anencephaly
NR Lumbar meningomyelocele
F - Anencephaly
F 1134 Anencephaly and
meningomyelocele
M 590 Iniencephaly
F 1432 Microcephaly and
encephalocele
F NR Microcephaly, frontal
encephalocele and a
meningomyelocele
NR NR Anencephaly
NR=not recorded
However, several large series of women receiving ovulation stimulation agents
for a variety of causes of infertility have been reported but without any indication
of an increased incidence of neural tube defects or indeed any congenital abnor-
mality among their offspring. Goldfarb, et al (1968) found no increase in the
incidence of congenital abnormalities in the offspring of women on clomiphene.
In 166 infants and 17 abortuses in their study, only two congenital abnormalities,
both haemangiomas, were noted. In the series reported by Whitelaw, et al (1970) of
88 pregnancies which resulted in 67 livebirths, there was no mention of congenital
abnormalities. However, of the 104 infants born to 86 women on clomiphene
reported by Hack, et al (1972), six had congenital abnormalities. One infant had a
double aorta, hypoplasia of the right arch and a preductile coarctation of left arch
with a patent ductus arteriosus; another infant had absence of second and fifth
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Sandler (I973) 1 Primigravidadigits; two additional infants had congenital dislocation of the hip; and another two
had pyloric stenosis. None of the 104 infants had neural tube defects. Although
they concluded that the "incidence of congenital malformations did not differ sig-
nificantly from that found in the general population", six of 104 infants with a
congenital abnormality should not be dismissed lightly.
An alternate explanation for the association of anencephaly and clomiphene is
that couples who have infants with neural tube defects are subfertile and, therefore,
likely to receive ovulation stimulation agents (Dyson & Kohler, 1973; James, 1973,
1974). Several epidemiological surveys of anencephaly have shown a longer fallow
interval or conception wait before the anencephalic birth than in controlled groups
(Smithells, et al, 1964; James, 1974). James (1974) using the data of the British
Perinatal Mortality Survey (1963) and taking only patients with no previous
obstetric history showed the following: of 134 cases of anencephaly, in 74 cases
the marriage to confinement interval exceeded the median of the distribution of the
control group. He concluded that although this finding was not statistically signifi-
cant, it did suggest that primiparous mothers of anencephalic infants have a longer
marriage to conception interval. As there is an association between dizygotic
twinning (due to double ovulation) and anencephaly, Elwood (1974) has suggested
that perhaps clomiphene acts via a mechanism which increases the risk of both.
Couples who produce infants with anencephaly may be subfertile, not because
they are less able to conceive, but because they have a high spontaneous abortion
rate (Record & McKeown, 1950; Coffey & Jessop, 1958; James, 1974). Thus,
among their pregnancies there is a higher proportion of recognised and unrecognised
spontaneous abortion.
There is undoubtedly a need for more information on the relationship between
fertility and neural tube defects. A prospective survey of women receiving clomi-
phene is being carried out and a complete ascertainment of families with an infant
with a neural tube defect born 1971-1974 inclusive, has been undertaken to deter-
mine some of the parameters of fertility. However, it is also important not to ignore
the possible teratogenic effect of clomiphene.
SUMMARY
This paper describes four patients who had five infants with neural tube defects
while receiving clomiphene for infertility. Of the five infants two had anencephaly
and/or spina bifida; one had iniencephaly; another, microcephaly and an encepha-
locele; and the fifth, microcephaly, a frontal encephalocele and a meningomyelocele.
The possible teratogenic effect of clomiphene is discussed but it is also suggested
that anencephalic-prone-couples are subfertile and thus anencephalic births would
be associated, but not casually, with the administration of drugs designed to alleviate
infertility.
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